Nomura Holdings Inc United Therapeutics Corp Transaction History

Nomura Holdings Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$228.26 - $319.04 $180,781 - $252,679	792 New	792 $252,000
Q2 2021 Aug 16, 2021	SELL	$170.47 - $211.93 $1.07 Million - $1.32 Million	-6,250 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$153.94 - $174.85 $962,125 - $1.09 Million	6,250 New	6,250 $1.05 Million
Q4 2018 Feb 14, 2019	SELL	$101.4 - $128.73 $164,775 - $209,186	-1,625 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$113.81 - $129.46 $396,058 - $450,520	-3,480 Reduced 68.17%	1,625 $205,000
Q2 2018 Aug 14, 2018	SELL	$101.14 - $118.31 $659,028 - $770,907	-6,516 Reduced 56.07%	5,105 $537,000
Q4 2017 Feb 14, 2018	BUY	$118.58 - $151.28 $568,116 - $724,782	4,791 Added 70.15%	11,621 $1.72 Million
Q3 2017 Nov 14, 2017	BUY	$114.6 - $136.81 $782,718 - $934,412	6,830	6,830 $802,000

668

42.8M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.